Skip to main content

Table 3 Demographic and general clinical characteristics of WNV patients (n = 66)

From: Identifying risks for severity of neurological symptoms in Hungarian West Nile virus patients

Gender and age distribution n (%)

Male

42 (63.3)

Female

24 (36.4)

Total

66

Age (average)

56.74 years

Age (median)

60.0 years

patients below 65 years old

43 (64.15)

- patients < 45 years old

19 (28.79)

- patients 45-65 years old

24 (36.4)

patients over 65 years old

23 (34.8)

Time between onset of neurological symptoms and hospital admission (days)

 average

6.01

 median

4.00

Number of Comorbidities n (%)

 None or 1 illness

37 (56.1)

 2 or more illnesses

29 (43.9)

Relevant medication n (%)

 None

59 (89.3)

 Immunsuppressive therapy

4(6.1)

 Active antitumor therapy

1 (1.5)

 Steroid therapy

1 (1.5)

 Data not available (NA)

1 (1.5)

General symptoms at presentation n (%)

 Fever

61 (92.42)

 Weakness and malaise

26 (39.4)

 Nausea, vomiting

26 (39.4)

 Skin rash

20 (30.3)

 Diarrhea

7 (10.6)

 Muscle/joint pain

7 (10.6)

 Abdominal pain

5 (7.6)

 Coughing, upper respiratory tract symptom

5 (7.6)